4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001628280-26-044890
Chief Financial Officer sold 1,112 shares at $17.99 ($20,005)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Scalzo Richard William · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-22 | Sale : show line 1 in the form 10b5-1 | −1,112 | $17.99 | $20,005 | 20,298 | D |
| Open-market sales · 1,112 sh · avg $17.99 · $20,005 | ||||||
Loading xslF345X06/wk-form4_1782245034.xml…